Table 2A.
Multivariable analysis for all-cause mortality (ACM).
| Variable | Hazard ratio (HR) | 95% CI Low | 95% CI High | p |
|---|---|---|---|---|
| Age (continuous) | 1.03 | 1.02 | 1.03 | <0.001 |
| Sex (female vs. male) | 1.10 | 0.89 | 1.35 | 0.38 |
| Race (other vs. AA) | 1.17 | 0.86 | 1.46 | 0.41 |
| BMI (continuous) | 0.99 | 0.98 | 1.01 | 0.25 |
| CAD (no vs. yes) | 1.25 | 0.10 | 1.56 | 0.055 |
| DM (no vs. yes) | 1.18 | 0.91 | 1.53 | 0.211 |
| Surgery Type (RN vs. PN) | 1.14 | 0.92 | 1.41 | 0.25 |
| Tumor stage (reference = Stage 1) | <0.001 | |||
| Stage 2 vs. Stage 1 | 1.66 | 1.12 | 2.48 | 0.013 |
| Stage 3 vs. Stage 1 | 2.25 | 1.73 | 2.93 | <0.001 |
| Stage 4 vs. Stage 1 | 1.32 | 1.07 | 1.64 | <0.001 |
| Metastasis (no vs. yes) | 2.00 | 1.58 | 2.53 | <0.001 |
| Last eGFR < 45 ml/min/1.73m² (no vs. yes) | 1.35 | 1.11 | 1.64 | 0.003 |
| NLR ≥ 2.27 (no vs. yes) | 1.32 | 1.07 | 1.64 | 0.011 |
| PLR ≥ 165 (no vs. yes) | 1.07 | 0.84 | 1.38 | 0.569 |
| AST/ALT ≥ 2.72 (no vs. yes) | 2.04 | 1.65 | 2.52 | <0.001 |